Press release
Lentiviral Vectors Market 2022: Growing Application in T-Cell Engineering and Bioprocessing
Lentiviral vectors are gene delivery mechanisms that are produced from the lentivirus of the human immunodeficiency virus type 1 (HIV-1). These vectors are mainly incompetent for replication, and hence, regarded as generally safe. Yet, they can successfully integrate into the genomic DNA of a wide variety of dividing and non-dividing mammalian cell types.Request For Free Sample Report of "Lentiviral Vectors Market"@ https://www.persistencemarketresearch.com/samples/33074
With recorded sales of US$ 127.6 Mn in 2021, the global lentiviral vectors market is predicted to experience high growth over the years ahead, owing to high product adoption globally. Demand for lentiviral vectors is estimated to surge at a CAGR of 11.4 % from 2022 to 2032.
Many genetic disorders are caused by gene mutations, which can be found in almost every cell in the body. As a result, these diseases affect a variety of physiological systems and the vast majority of them are incurable. Gene therapy has been utilized to cure a few ailments; however, most therapeutic approaches for genetic conditions do not change the underlying genetic abnormality. Changing a person's DNA to prevent or treat an illness is a novel approach.
Gene therapy with lentiviral vectors is a method of inserting, modifying, or deleting genes in organisms using lentivirus to cure genetic problems. As a result, future expansion of the market will be driven by the use of lentiviral vectors for the treatment of genetic disorders.
Key Takeaways from Market Study
Kits, a subgroup of the product segment, are widely used than reagents and consumables in terms of volume. The segment held 71.7% market share by value in 2021.
Lentiviral vectors are mostly used for the treatment of cancer. The cancer segment, by indication, accounted for a market share of around 65.4% in 2021, which is the highest of all measured across the market.
Academic and research institutes are focused on the development of various new treatment options based on lentiviral vectors for the treatment of various genetic, infectious, and other disorders. Thus, academic and research institutes held the highest market share of 49.1% by value in 2021.
The North America lentiviral vectors market accounted for 35.5% of the global market share in 2021. This is due to the presence of major key players in this region.
"Growing demand for lentiviral vectors, rise in prevalence of infectious diseases, and increasing burden of genetic disorders will drive growth of the lentiviral vectors market over the coming years," says an analyst of Persistence Market Research.
Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/33074
Market Competition
Key suppliers of lentiviral vectors are focused on strategic collaborations and acquisitions to increase their market share value.
SIRION Biotech, for example, established a collaboration with the Centre for Genomic Regulation in February 2022 to invent a new version of AAV vectors for type 1 and type 2 diabetic gene therapy.
In April 2022, Charles River announced the acquisition of Explora BioLabs.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the lentiviral vectors market in its latest study, presenting a historical demand assessment of 2017 - 2021 and projections for 2022 - 2032.
The research study is based on the products (kits [lentiviral packing systems, lentiviral expression systems, lentiviral promoter kits, and lentiviral fusion tags], reagents & consumables), indication (cancer, genetic disorders, infectious diseases, veterinary diseases, and others), and end user (biotechnology companies, pharmaceutical companies, contract research organizations (CROs), and academic and research institutes), across seven key regions of the world.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/33074
Key Questions Answered in This Report.
What are the Roadblocks for Lentiviral Vectors Market Suppliers?
What are the Key Opportunities for Lentiviral Vectors Market Manufacturers?
How is Focus on Safety Influencing Lentiviral Vectors Market Demand?
What is the Regulatory Impact on Global Sales of Lentiviral Vectors Market?
Which Region Offers the Largest Opportunity for Sales of Lentiviral Vectors Market?
Where Does the U.S. Stand in the Market for Lentiviral Vectors Market?
What Is the Outlook for Lentiviral Vectors Market Manufacturers in China?
Why is Germany a Lucrative Market for Lentiviral Vectors Market Manufacturers?
Why Will Belgium Outpace Other European Markets for Lentiviral Vectors Market?
Why is There High Demand for Tires in Lentiviral Vectors Market?
Why are Sales of Lentiviral Vectors Market Surging?
Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lentiviral Vectors Market 2022: Growing Application in T-Cell Engineering and Bioprocessing here
News-ID: 2821491 • Views: …
More Releases from Persistence Market Research
Nutmeg Butter Market to Reach $57.6M by 2033, Driven by Rising Demand in Food
The global nutmeg butter market is witnessing significant growth, driven by rising demand from the cosmetic, pharmaceutical, and food industries. The market is estimated to be valued at US$ 39.1 million in 2026 and is projected to reach US$ 57.6 million by 2033, reflecting a compound annual growth rate (CAGR) of 5.7% over the forecast period from 2026 to 2033.
The growth of the nutmeg butter market is largely attributed to…
eVTOL Aircraft Market to Reach US$ 8,079.7 Mn by 2033 as Joby Aviation, Lilium, …
The global eVTOL Aircraft market is emerging as one of the most dynamic sectors within advanced air mobility, showing remarkable growth due to technological advancements, increasing urban congestion, and rising demand for faster and more sustainable transportation solutions. eVTOL, or electric Vertical Take-Off and Landing aircraft, are redefining air travel by combining electric propulsion with vertical lift capabilities, making them suitable for urban air taxis, cargo transport, and specialized aviation…
Acai Berry Market to Reach $2.69B by 2033 Driven by Rising Health Awareness
The global acai berry market is poised for significant expansion over the next decade, reflecting rising consumer interest in superfoods and health-focused diets. Current estimates indicate that the market is likely to be valued at US$ 1.64 billion in 2026 and is projected to reach US$ 2.69 billion by 2033, recording a compound annual growth rate (CAGR) of 7.3% during the forecast period from 2026 to 2033. This strong growth…
Tea Packaging Machine Market to Grow to US$2.3 Billion by 2033 Driven by Automat …
According to the latest study by Persistence Market Research, the global tea packaging machine market is likely to be valued at US$1.6 billion in 2026 and is projected to reach US$2.3 billion by 2033, expanding at a CAGR of 5.4% between 2026 and 2033. The market growth is primarily driven by structurally rising tea consumption in Asia Pacific, accelerated adoption of automated packaging lines, and increasing demand for convenience-oriented packaging…
More Releases for Lentiviral
Key Factor Supporting Lentiviral Vector Market Development in 2025: Lentiviral V …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Lentiviral Vector Market Size By 2025?
The size of the lentiviral vector market has expanded significantly in the past few years. Projections show an increase from $14.37 billion in 2024 to $16.48 billion in 2025, reflecting a compound annual growth rate (CAGR) of 14.7%. Factors…
Emerging Lentiviral Vector Market Trend 2025-2034: Technological Advancements In …
How Is the Lentiviral Vector Market Projected to Grow, and What Is Its Market Size?
The lentiviral vector market will grow from $14.37 billion in 2024 to $16.62 billion in 2025, at a CAGR of 15.7%. This market is expanding due to the growing prevalence of genetic disorders, increasing demand for gene delivery systems, biotech and pharmaceutical investments, and regulatory approvals for related therapies.
The lentiviral vector market is expected to grow…
Lentiviral Vector Market Size, Share, and Growth Opportunities 2023 -2030
This Lentiviral Vector Market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market segmentation, thorough analysis of major market players, trends in consumer and supply…
Lentiviral Vectors Market Size 2024 to 2031.
Market Overview and Report Coverage
Lentiviral vectors are a type of viral vector used in gene therapy to deliver genetic material into target cells for both research and therapeutic purposes. These vectors are derived from lentiviruses, a type of retrovirus that can integrate their genetic material into the DNA of host cells.
The Lentiviral Vectors Market is poised for significant growth in the coming years, with a projected CAGR of…
The Lentiviral Vectors Market To Strive With Vertical Saas
Lentiviral vectors are gene delivery mechanisms that are produced from the lentivirus of the human immunodeficiency virus type 1 (HIV-1). These vectors are mainly incompetent for replication, and hence, regarded as generally safe. Yet, they can successfully integrate into the genomic DNA of a wide variety of dividing and non-dividing mammalian cell types.
With recorded sales of US$ 127.6 Mn in 2021, the global lentiviral vectors market is predicted to experience…
Lentiviral Vector Manufacturing Market Size
According to a new market research report published by Global Market Estimates, the Global Lentiviral Vector Manufacturing Market is projected to grow at a CAGR value of 17.8% from 2022 and 2027.
Charles River Laboratories, Vivebiotech, Thermo Fisher Scientific. Inc., GenScript, Creative Biogene, OriGene Technologies, Inc., Oxford Biomedica, Merck KGaA, Takara Bio, Pall Corporation, ITSBio Inc., ANDELYN BIOSCIENCES, Sino Biological Inc., Cellomics Technology, LLC, Virica Biotech, Cell Biolabs, Inc., SignaGen…
